Voltage-gated Ca2+ channels are important regulators of membrane potential in cardiac, skeletal and smooth muscle cells and cardiovascular neurons. Just as important is the Ca2+ the enters via these channels acts as a second messenger upon ion channels, C kinase, proteases, calmodulin, etc. The structure of Ca2+ channels in skeletal muscle is tetrameric consisting of alpha 1, alpha2, beta, and gamma subunits; elsewhere the subunit composition is unknown. We showed that this alpha1 subunit by itself can function as a Ca2+ channel and dihydropyridine receptor (Perez-Reyes et al., 1990). This was achieved by stably transfecting alpha1 into murine L cells which are devoid of all subunits and so not express Ca2+ currents. Mikami et al. (1990) showed that the alpha1 subunit from cardiac muscle expressed Ca2+ currents in Xenopus oocytes. Since oocytes have an endogenous Ca2+ current, the properties of alpha 1 were not specified as clearly. The molecular mechanisms of voltage sensitivity, divalent cation selectivity and regulation of Ca2+ channels are largely unknown. We will examine these properties for both alpha 1 subunits in combination with different skeletal muscle alpha 2, beta, gamma subunits and different cardiac muscle subunits as they become available. Expression will be studied in L cells and oocytes. Chimeras of the two alpha 1s will be used to determine the repeats responsible for the differences between skeletal and cardiac muscle Ca2+ currents. Chimeras with Na+ and K+ channels will be developed to determine the repeats important for gating and selectivity. The search for the essential parts will be narrowed by using segments from candidate repeats. These will be introduced into a K+ channel which has been genetically engineered for segment swapping. Sites for regulation by G proteins will be tested using similar approaches.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL037044-07
Application #
3844533
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Kiehn, J; Lacerda, A E; Brown, A M (1999) Pathways of HERG inactivation. Am J Physiol 277:H199-210
Accili, E A; Kuryshev, Y A; Wible, B A et al. (1998) Separable effects of human Kvbeta1.2 N- and C-termini on inactivation and expression of human Kv1.4. J Physiol 512 ( Pt 2):325-36
Suh-Kim, H; Wei, X; Birnbaumer, L (1996) Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker. Mol Pharmacol 50:1330-7
Kiehn, J; Wible, B; Lacerda, A E et al. (1996) Mapping the block of a cloned human inward rectifier potassium channel by dofetilide. Mol Pharmacol 50:380-7
Dumaine, R; Wang, Q; Keating, M T et al. (1996) Multiple mechanisms of Na+ channel--linked long-QT syndrome. Circ Res 78:916-24
Jarolimek, W; Soman, K V; Alam, M et al. (1996) Structure-activity relationship of quaternary ammonium ions at the external tetraethylammonium binding site of cloned potassium channels. Mol Pharmacol 49:165-71
Pascual, J M; Shieh, C C; Kirsch, G E et al. (1995) K+ pore structure revealed by reporter cysteines at inner and outer surfaces. Neuron 14:1055-63
Crumb Jr, W J; Wible, B; Arnold, D J et al. (1995) Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. Mol Pharmacol 47:181-90
el-Hayek, R; Antoniu, B; Wang, J et al. (1995) Identification of calcium release-triggering and blocking regions of the II-III loop of the skeletal muscle dihydropyridine receptor. J Biol Chem 270:22116-8
Parent, L; Gopalakrishnan, M (1995) Glutamate substitution in repeat IV alters divalent and monovalent cation permeation in the heart Ca2+ channel. Biophys J 69:1801-13

Showing the most recent 10 out of 131 publications